Jeff Garro
Stock Analyst at Stephens & Co.
(1.00)
# 3,563
Out of 4,784 analysts
55
Total ratings
28.21%
Success rate
-12.35%
Average return
Main Sectors:
Stocks Rated by Jeff Garro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TBRG TruBridge | Maintains: Equal-Weight | $23 → $28 | $28.11 | -0.39% | 2 | Mar 11, 2025 | |
| VEEV Veeva Systems | Reiterates: Overweight | $280 | $234.21 | +19.55% | 2 | Mar 6, 2025 | |
| HCAT Health Catalyst | Maintains: Equal-Weight | $7 → $5 | $4.55 | +9.89% | 4 | Mar 6, 2025 | |
| CERT Certara | Reiterates: Overweight | $17 | $9.91 | +71.54% | 5 | Feb 27, 2025 | |
| ACCD Accolade | Reiterates: Equal-Weight | $7.03 | $6.99 | +0.57% | 7 | Feb 12, 2025 | |
| EVH Evolent Health | Maintains: Equal-Weight | $16 → $12 | $9.60 | +25.00% | 5 | Jan 21, 2025 | |
| PRVA Privia Health Group | Reiterates: Overweight | $26 | $22.59 | +15.10% | 3 | Jan 7, 2025 | |
| DH Definitive Healthcare | Initiates: Equal-Weight | $5 | $2.94 | +70.07% | 1 | Dec 20, 2024 | |
| DOCS Doximity | Initiates: Equal-Weight | $55 | $58.51 | -6.00% | 1 | Dec 20, 2024 | |
| OPRX OptimizeRx | Initiates: Equal-Weight | $5.5 | $8.64 | -36.34% | 3 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $250 | $177.39 | +40.93% | 2 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $12.51 | +35.89% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $24.29 | +60.56% | 1 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $26.00 | +7.69% | 8 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $28 | $8.09 | +246.11% | 2 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $18.30 | +9.29% | 3 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $3.9 | $3.00 | +30.00% | 2 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $3 | $3.40 | -11.76% | 3 | May 6, 2022 |
TruBridge
Mar 11, 2025
Maintains: Equal-Weight
Price Target: $23 → $28
Current: $28.11
Upside: -0.39%
Veeva Systems
Mar 6, 2025
Reiterates: Overweight
Price Target: $280
Current: $234.21
Upside: +19.55%
Health Catalyst
Mar 6, 2025
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.55
Upside: +9.89%
Certara
Feb 27, 2025
Reiterates: Overweight
Price Target: $17
Current: $9.91
Upside: +71.54%
Accolade
Feb 12, 2025
Reiterates: Equal-Weight
Price Target: $7.03
Current: $6.99
Upside: +0.57%
Evolent Health
Jan 21, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $9.60
Upside: +25.00%
Privia Health Group
Jan 7, 2025
Reiterates: Overweight
Price Target: $26
Current: $22.59
Upside: +15.10%
Definitive Healthcare
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5
Current: $2.94
Upside: +70.07%
Doximity
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $58.51
Upside: -6.00%
OptimizeRx
Dec 20, 2024
Initiates: Equal-Weight
Price Target: $5.5
Current: $8.64
Upside: -36.34%
Dec 20, 2024
Initiates: Overweight
Price Target: $250
Current: $177.39
Upside: +40.93%
Dec 9, 2024
Initiates: Buy
Price Target: $17
Current: $12.51
Upside: +35.89%
Nov 15, 2024
Initiates: Overweight
Price Target: $39
Current: $24.29
Upside: +60.56%
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $26.00
Upside: +7.69%
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $8.09
Upside: +246.11%
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $18.30
Upside: +9.29%
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $3.00
Upside: +30.00%
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $3.40
Upside: -11.76%